Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 1/22/2020 8:00:00 PM
Infants don't try things randomly or mimic their parents, they try new things based off their own experiences:…
BCH Innovation News @BCH_Innovation 1/22/2020 6:00:00 PM
Researchers have found a connection between belly fat and a future #heartattack or #stroke: via @cnnhealth
BCH Innovation News @BCH_Innovation 1/22/2020 4:00:01 PM
New study reveals the survival rate for patients receiving a #bonemarrow transplant have increased:…
BCH Innovation News @BCH_Innovation 1/22/2020 2:00:01 PM
Researchers have discovered a new type of antibiotic-resistant #bacteria: via @medical_xpress
BCH Innovation News @BCH_Innovation 1/21/2020 7:00:01 PM
Targeting #LIN28: A new way to maintain fetal #hemoglobin production in #sicklecell disease?:…
BCH Innovation News @BCH_Innovation 1/21/2020 6:00:01 PM
In the U.S. alone, over 2.5 million people experience a traumatic brain injury, or #TBI, each year:…
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer